about
The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease ProgressionThe dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutationsMicroRNA aberrations: An emerging field for gallbladder cancer managementDelaying Chemotherapy in the Treatment of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerThe Engineered Chloroplast Genome Just Got SmarterIL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.Engineered chloroplast dsRNA silences cytochrome p450 monooxygenase, V-ATPase and chitin synthase genes in the insect gut and disrupts Helicoverpa armigera larval development and pupationAberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathwayTargeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells.microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.microRNAs Databases: Developmental Methodologies, Structural and Functional Annotations.MiRNA-based therapeutic intervention of cancer.miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.Snail-Modulated MicroRNA 493 Forms a Negative Feedback Loop with the Insulin-Like Growth Factor 1 Receptor Pathway and Blocks TumorigenesisA multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.The roles of microRNAs in the progression of castration-resistant prostate cancer.MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoAEmerging role of microRNAs in cancer stem cells: Implications in cancer therapyMeta-analysis of microRNAs expression in head and neck cancer: uncovering association with outcome and mechanisms.Piceatannol induced apoptosis through up-regulation of microRNA-181a in melanoma cells.Comparative aspects of MicroRNA Expression in Canine and Human Cancer.Acquisition of an oncogenic fusion protein is sufficient to globally alter the landscape of miRNA expression to inhibit myogenic differentiation.Identification of Viscum album L. miRNAs and prediction of their medicinal values.miRNAs as Potential Treatment Targets and Treatment Options in Cancer.Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma.Integrated Nanovaccine with MicroRNA-148a Inhibition Reprograms Tumor-Associated Dendritic Cells by Modulating miR-148a/DNMT1/SOCS1 Axis.The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer.MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway.Microprocessor depends on hemin to recognize the apical loop of primary microRNA.
P2860
Q26744831-716FEA0C-6CD0-43ED-A678-B6C69CB646EBQ26753387-99EA161C-10C5-478C-994D-4B2B245C0344Q26768416-0D4B6080-401E-4677-B917-EC5BAD3598A2Q26770482-04F35FE8-1EFF-491B-B62A-F31FF7E31A16Q26781748-3E90CFB2-1189-40E7-801F-393307C90C90Q33889122-70C4B100-6F79-45C8-AD1B-82AD6A795A1DQ35909883-96A5E12E-9A36-4310-AD86-5861DD4C1AFFQ35936553-A99133B1-F62E-4747-81D2-70435AF0C17DQ36184892-02E31C26-A77A-46AE-8338-0F6E4EC6AC28Q36992190-0A7AF1B9-4219-4068-ADFC-8DD951D58455Q37107187-D7449F10-F168-4691-85C0-A2D3C5B220A6Q37362485-725C021E-A842-4914-ABDE-F6FC4265D021Q37508895-827E2037-DA46-4F2B-AEB8-4F18D0A8BA11Q37641780-520923E0-C128-4FB0-94A6-52D0E061B0A8Q38309242-38CE4DEC-C358-458B-A1CD-703D6F23CFFEQ38449368-29AE3D3D-4E38-4259-A1EF-EBE84C043778Q38524274-DC1A7658-4F5B-46D0-A2EE-7881090EED8BQ38591803-7F0D51E4-9C29-4A54-92DA-154DA9045E5FQ38726530-82792052-DE2F-47C6-B720-09AEF4B0814CQ38815929-065C21EC-4690-409A-B71D-66C11088B033Q38859577-D2C75680-2285-4CD8-AAC2-37C63D7E12E7Q38986557-11924FB7-BCE6-4095-96C6-74F5EB3E446DQ41457379-1EEAD251-995F-4F48-B73D-0D5C891D0CF1Q41548123-013E01CD-F27D-4B81-AE41-A00403C7C77BQ42690681-AC691DA6-D3FC-4D24-9D98-C19B6C590B2BQ46304395-B3F3A3E0-E8A0-43C7-AF08-407C220F27EFQ46561228-A7F765EC-1912-4CD3-8A3F-A37DFF66C62DQ47122928-012CA730-ED4F-4BA8-B922-48E0DD3C09ADQ47730917-08995674-C97F-4A79-B14C-5A7C6226781EQ48256868-C8EC0291-650F-4267-91F6-07CFD76CA22EQ50284067-438F9050-1D8D-4E50-AF37-3006B2D4830DQ51639107-C38643F5-539D-4E1E-B3D5-48EC5B0337C3Q51764980-74274F7D-3A36-456A-B802-EB179AB4FB27Q55209609-913F5497-9105-454B-A4E4-8993179C086CQ55251303-38086A71-A5D6-46B7-8E81-E74A222E246A
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
microRNA therapies in cancer.
@en
type
label
microRNA therapies in cancer.
@en
prefLabel
microRNA therapies in cancer.
@en
P2860
P356
P1476
microRNA therapies in cancer.
@en
P2093
Sacha I Rothschild
P2860
P2888
P356
10.1186/2052-8426-2-7
P577
2014-03-04T00:00:00Z
P5875
P6179
1009390760